A Critical Assessment of Treatment Options for Idiopathic Pulmonary Fibrosis

Chest - United States
doi 10.1016/s0012-3692(16)46920-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Idiopathic Pulmonary Fibrosis: Treatment Options in Pursuit of Evidence-Based Approaches

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2006English

Idiopathic Pulmonary Fibrosis

Pulmonologiya
PulmonaryRespiratory Medicine
2015English

Idiopathic Pulmonary Fibrosis

2020English

Idiopathic Pulmonary Fibrosis: What Is the Best Treatment?

Barcelona Respiratory Network
2017English

Etiology and Treatment of Cough in Idiopathic Pulmonary Fibrosis

Respiratory Medicine
PulmonaryRespiratory Medicine
2017English

Diagnostic Criteria for Idiopathic Pulmonary Fibrosis

Lancet Respiratory Medicine,The
PulmonaryRespiratory Medicine
2018English

Triple Therapy for Idiopathic Pulmonary Fibrosis

Thorax
PulmonaryRespiratory Medicine
2012English

Emerging Drugs for Idiopathic Pulmonary Fibrosis

Expert Opinion on Emerging Drugs
Pharmacology
2011English

Epigenomics of Idiopathic Pulmonary Fibrosis

American Journal of Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy